Literature DB >> 18714204

Assessment of adherence to antiretroviral therapy in perinatally HIV-infected children and youth using self-report measures and pill count.

John J Farley1, Grace Montepiedra, Deborah Storm, Patricia A Sirois, Kathleen Malee, Patricia Garvie, Betsy Kammerer, Sylvie Naar-King, Sharon Nichols.   

Abstract

BACKGROUND: Parent/caregiver or child/youth self-report and pill counts are commonly used methods for assessing adherence to antiretroviral therapy among children and youth with HIV. The purpose of this study was to compare these different methods with one another and with viral load.
METHODS: Randomly selected parent/caregiver and child/youth dyads were interviewed using several adherence self-report measures and an announced pill count was performed. Adherence assessment methods were compared with one another and their relative validity was assessed by comparison with the child's viral load close to the time of the interview or pill count, adjusting for primary caregiver, child age, and child disclosure of the diagnosis.
RESULTS: There were 151 evaluable participants. Adherence rate by pill count was >or=90% in 52% of participants, was significantly associated with log(RNA) viral load (p = .032), and had significant agreement with viral load <400 copies/mL. However, pill count data were incomplete for 26% of participants. With similar proportions considered adherent, a variety of self-report adherence assessment methods also were associated with log(RNA) viral load including: "no dose missed within the past 1 month" (p = .054 child/youth interview, p = .004 parent/caregiver interview), and no barrier to adherence identified (p = .085 child/youth interview, p = .015 parent/caregiver interview). Within-rater and inter-rater agreement was high among self-report methods. Three day recall of missed doses was not associated with viral load.
CONCLUSION: Findings demonstrate the validity of adherence assessment strategies that allow the parent/caregiver or child/youth to report on adherence over a longer period of time and to identify adherence barriers. Adherence assessed by announced pill count was robustly associated with viral load, but there was incomplete data for many participants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18714204      PMCID: PMC6677401          DOI: 10.1097/DBP.0b013e3181856d22

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  23 in total

1.  Clinical assessment of medication adherence among HIV-infected children: examination of the Treatment Interview Protocol (TIP).

Authors:  S L Marhefka; J J Farley; J R Rodrigue; L L Sandrik; J W Sleasman; V J Tepper
Journal:  AIDS Care       Date:  2004-04

2.  Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.

Authors:  S L Gortmaker; M Hughes; J Cervia; M Brady; G M Johnson; G R Seage; L Y Song; W M Dankner; J M Oleske
Journal:  N Engl J Med       Date:  2001-11-22       Impact factor: 91.245

3.  Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs.

Authors:  R G Steele; B Anderson; B Rindel; M L Dreyer; K Perrin; R Christensen; V Tyc; P M Flynn
Journal:  AIDS Care       Date:  2001-10

4.  Adherence to medication regimens among children with human immunodeficiency virus infection.

Authors:  C Reddington; J Cohen; A Baldillo; M Toye; D Smith; C Kneut; A Demaria; J Bertolli; H W Hsu
Journal:  Pediatr Infect Dis J       Date:  2000-12       Impact factor: 2.129

5.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG).

Authors:  M A Chesney; J R Ickovics; D B Chambers; A L Gifford; J Neidig; B Zwickl; A W Wu
Journal:  AIDS Care       Date:  2000-06

6.  Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.

Authors:  Russell B Van Dyke; Sophia Lee; George M Johnson; Andrew Wiznia; Kathleen Mohan; Kenneth Stanley; Edward V Morse; Paul A Krogstad; Sharon Nachman
Journal:  Pediatrics       Date:  2002-04       Impact factor: 7.124

Review 7.  Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications.

Authors:  L G Miller; R D Hays
Journal:  AIDS Read       Date:  2000-03

8.  Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial.

Authors:  Diana M Gibb; Ruth L Goodall; Vania Giacomet; Laura McGee; Alex Compagnucci; Hermione Lyall
Journal:  Pediatr Infect Dis J       Date:  2003-01       Impact factor: 2.129

9.  Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping.

Authors:  John Farley; Susan Hines; Amy Musk; Sherley Ferrus; Vicki Tepper
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

10.  The reliability of reports of medical adherence from children with HIV and their adult caregivers.

Authors:  Curtis Dolezal; Claude Mellins; Elizabeth Brackis-Cott; Elaine J Abrams
Journal:  J Pediatr Psychol       Date:  2003 Jul-Aug
View more
  20 in total

1.  Allocation of family responsibility for illness management in pediatric HIV.

Authors:  Sylvie Naar-King; Grace Montepiedra; Sharon Nichols; John Farley; Patricia A Garvie; Betsy Kammerer; Kathleen Malee; Patricia A Sirois; Deborah Storm
Journal:  J Pediatr Psychol       Date:  2008-06-27

2.  Cognitive, academic, and behavioral correlates of medication adherence in children and adolescents with perinatally acquired HIV infection.

Authors:  Sharon L Nichols; Grace Montepiedra; John J Farley; Patricia A Sirois; Kathleen Malee; Betsy Kammerer; Patricia A Garvie; Sylvie Naar-King
Journal:  J Dev Behav Pediatr       Date:  2012-05       Impact factor: 2.225

3.  Social ecological predictors of longitudinal HIV treatment adherence in youth with perinatally acquired HIV.

Authors:  Sylvie Naar-King; Grace Montepiedra; Patricia Garvie; Betsy Kammerer; Kathleen Malee; Patricia A Sirois; Lisa Aaron; Sharon L Nichols
Journal:  J Pediatr Psychol       Date:  2013-04-28

4.  Relationship between viral load and self-report measures of medication adherence among youth with perinatal HIV infection.

Authors:  Ann Usitalo; Erin Leister; Katherine Tassiopoulos; Susannah Allison; Kathleen Malee; Mary E Paul; Renee Smith; Russell B Van Dyke; George R Seage; Claude A Mellins
Journal:  AIDS Care       Date:  2013-06-26

5.  Prospective memory in youth with perinatally-acquired HIV infection.

Authors:  Lynnette L Harris; Miriam C Chernoff; Sharon L Nichols; Paige L Williams; Patricia A Garvie; Cenk Yildirim; Stephen R McCauley; Steven Paul Woods
Journal:  Child Neuropsychol       Date:  2017-08-07       Impact factor: 2.500

6.  Association of Adolescent- and Caregiver-Reported Antiretroviral Therapy Adherence with HIV Viral Load Among Perinatally-infected South African Adolescents.

Authors:  Kirsty Brittain; Nana Akua Asafu-Agyei; Jacqueline Hoare; Linda-Gail Bekker; Helena Rabie; James Nuttall; Paul Roux; Dan J Stein; Heather J Zar; Landon Myer
Journal:  AIDS Behav       Date:  2018-03

7.  Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report.

Authors:  Ashley L Buchanan; Grace Montepiedra; Patricia A Sirois; Betsy Kammerer; Patricia A Garvie; Deborah S Storm; Sharon L Nichols
Journal:  Pediatrics       Date:  2012-04-16       Impact factor: 7.124

8.  Assessment of HIV antiretroviral therapy adherence by measuring drug concentrations in hair among children in rural Uganda.

Authors:  Peter K Olds; Julius P Kiwanuka; Denis Nansera; Yong Huang; Peter Bacchetti; Chengshi Jin; Monica Gandhi; Jessica E Haberer
Journal:  AIDS Care       Date:  2014-12-06

9.  Adherence and viral suppression among infants and young children initiating protease inhibitor-based antiretroviral therapy.

Authors:  Chloe A Teasdale; Elaine J Abrams; Ashraf Coovadia; Renate Strehlau; Leigh Martens; Louise Kuhn
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

10.  Mental Health and Antiretroviral Adherence Among Youth Living With HIV in Rwanda.

Authors:  Mary C Smith Fawzi; Lauren Ng; Fredrick Kanyanganzi; Catherine Kirk; Justin Bizimana; Felix Cyamatare; Christina Mushashi; Taehoon Kim; Yvonne Kayiteshonga; Agnes Binagwaho; Theresa S Betancourt
Journal:  Pediatrics       Date:  2016-10       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.